A Real-World Study of Guselkumab in Chinese Participants With Ulcerative Colitis
Clinical trial NCT07302360 · RECRUITING
Trial details
- NCT number
- NCT07302360
- Sponsor
- Xian-Janssen Pharmaceutical Ltd.
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-12-11
- Primary completion
- 2028-06-30
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.